APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Varicella Zoster Infection Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Varicella Zoster Infection Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174045230321 December 2025198 pages

Choose your research edition.

Industry ResearchVaricella Zoster Infection Treatment Drugs Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Varicella Zoster Infection Treatment Drugs Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Varicella Zoster Infection Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Varicella Zoster Infection Treatment Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Varicella Zoster Infection Treatment Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Varicella Zoster Infection Treatment Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Varicella Zoster Infection Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Varicella Zoster Infection Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Varicella Zoster Infection Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Varicella Zoster Infection Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Varicella Zoster Infection Treatment Drugs include Astrazeneca, GlaxoSmithKline, Pfizer, Eli Lilly, Roche, Merck, Novartis, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Varicella Zoster Infection Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Varicella Zoster Infection Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Varicella Zoster Infection Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Varicella Zoster Infection Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Varicella Zoster Infection Treatment Drugs Segment by Company

Astrazeneca

GlaxoSmithKline

Pfizer

Eli Lilly

Roche

Merck

Novartis

Johnson & Johnson

Sanofi

Abbott

Varicella Zoster Infection Treatment Drugs Segment by Type

Acyclovir

Famciclovir

Valacyclovir

Others

Varicella Zoster Infection Treatment Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Varicella Zoster Infection Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Varicella Zoster Infection Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Varicella Zoster Infection Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Varicella Zoster Infection Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Varicella Zoster Infection Treatment Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Varicella Zoster Infection Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Varicella Zoster Infection Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Varicella Zoster Infection Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Varicella Zoster Infection Treatment Drugs Industry Trends Table 2. Varicella Zoster Infection Treatment Drugs Industry Drivers Table 3. Varicella Zoster Infection Treatment Drugs Industry Opportunities and Challenges Table 4. Varicella Zoster Infection Treatment Drugs Industry Restraints Table 5. Global Varicella Zoster Infection Treatment Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Varicella Zoster Infection Treatment Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Manufacturers Table 9. Global Varicella Zoster Infection Treatment Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Varicella Zoster Infection Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Varicella Zoster Infection Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Varicella Zoster Infection Treatment Drugs Manufacturers, Product Type & Application Table 13. Global Varicella Zoster Infection Treatment Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Varicella Zoster Infection Treatment Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Acyclovir Table 17. Major Manufacturers of Famciclovir Table 18. Major Manufacturers of Valacyclovir Table 19. Major Manufacturers of Others Table 20. Global Varicella Zoster Infection Treatment Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Varicella Zoster Infection Treatment Drugs Sales by Type (2021-2026) & (k units) Table 22. Global Varicella Zoster Infection Treatment Drugs Sales by Type (2027-2032) & (k units) Table 23. Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Type (2021-2026) Table 24. Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Type (2027-2032) Table 25. Global Varicella Zoster Infection Treatment Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Varicella Zoster Infection Treatment Drugs Revenue by Type (2021-2026) & (k units) Table 27. Global Varicella Zoster Infection Treatment Drugs Revenue by Type (2027-2032) & (k units) Table 28. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Pharmacies Table 31. Major Manufacturers of Online Pharmacies Table 32. Major Manufacturers of Retail Pharmacies Table 33. Global Varicella Zoster Infection Treatment Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Varicella Zoster Infection Treatment Drugs Sales by Application (2021-2026) & (k units) Table 35. Global Varicella Zoster Infection Treatment Drugs Sales by Application (2027-2032) & (k units) Table 36. Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Application (2021-2026) Table 37. Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Application (2027-2032) Table 38. Global Varicella Zoster Infection Treatment Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Varicella Zoster Infection Treatment Drugs Revenue by Application (2021-2026) & (k units) Table 40. Global Varicella Zoster Infection Treatment Drugs Revenue by Application (2027-2032) & (k units) Table 41. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Varicella Zoster Infection Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Varicella Zoster Infection Treatment Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Region (2021-2026) Table 46. Global Varicella Zoster Infection Treatment Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Varicella Zoster Infection Treatment Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Varicella Zoster Infection Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Varicella Zoster Infection Treatment Drugs Sales by Country (2021-2026) & (k units) Table 50. North America Varicella Zoster Infection Treatment Drugs Sales by Country (2027-2032) & (k units) Table 51. Europe Varicella Zoster Infection Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Varicella Zoster Infection Treatment Drugs Sales by Country (2021-2026) & (k units) Table 53. Europe Varicella Zoster Infection Treatment Drugs Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Varicella Zoster Infection Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Varicella Zoster Infection Treatment Drugs Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Varicella Zoster Infection Treatment Drugs Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Sales by Country (2027-2032) & (k units) Table 60. Global Varicella Zoster Infection Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Varicella Zoster Infection Treatment Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Varicella Zoster Infection Treatment Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Region (2027-2032) Table 65. Astrazeneca Company Information Table 66. Astrazeneca Business Overview Table 67. Astrazeneca Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Astrazeneca Varicella Zoster Infection Treatment Drugs Product Portfolio Table 69. Astrazeneca Recent Development Table 70. GlaxoSmithKline Company Information Table 71. GlaxoSmithKline Business Overview Table 72. GlaxoSmithKline Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GlaxoSmithKline Varicella Zoster Infection Treatment Drugs Product Portfolio Table 74. GlaxoSmithKline Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Varicella Zoster Infection Treatment Drugs Product Portfolio Table 79. Pfizer Recent Development Table 80. Eli Lilly Company Information Table 81. Eli Lilly Business Overview Table 82. Eli Lilly Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lilly Varicella Zoster Infection Treatment Drugs Product Portfolio Table 84. Eli Lilly Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Roche Varicella Zoster Infection Treatment Drugs Product Portfolio Table 89. Roche Recent Development Table 90. Merck Company Information Table 91. Merck Business Overview Table 92. Merck Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Merck Varicella Zoster Infection Treatment Drugs Product Portfolio Table 94. Merck Recent Development Table 95. Novartis Company Information Table 96. Novartis Business Overview Table 97. Novartis Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Novartis Varicella Zoster Infection Treatment Drugs Product Portfolio Table 99. Novartis Recent Development Table 100. Johnson & Johnson Company Information Table 101. Johnson & Johnson Business Overview Table 102. Johnson & Johnson Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Johnson & Johnson Varicella Zoster Infection Treatment Drugs Product Portfolio Table 104. Johnson & Johnson Recent Development Table 105. Sanofi Company Information Table 106. Sanofi Business Overview Table 107. Sanofi Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Sanofi Varicella Zoster Infection Treatment Drugs Product Portfolio Table 109. Sanofi Recent Development Table 110. Abbott Company Information Table 111. Abbott Business Overview Table 112. Abbott Varicella Zoster Infection Treatment Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Abbott Varicella Zoster Infection Treatment Drugs Product Portfolio Table 114. Abbott Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Varicella Zoster Infection Treatment Drugs Distributors List Table 118. Varicella Zoster Infection Treatment Drugs Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Varicella Zoster Infection Treatment Drugs Product Image Figure 2. Global Varicella Zoster Infection Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Varicella Zoster Infection Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Varicella Zoster Infection Treatment Drugs Sales (2021-2032) & (k units) Figure 5. Global Varicella Zoster Infection Treatment Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Varicella Zoster Infection Treatment Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Acyclovir Image Figure 9. Famciclovir Image Figure 10. Valacyclovir Image Figure 11. Others Image Figure 12. Global Varicella Zoster Infection Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Varicella Zoster Infection Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Varicella Zoster Infection Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Type (2021-2032) Figure 18. Hospital Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Retail Pharmacies Image Figure 21. Global Varicella Zoster Infection Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Varicella Zoster Infection Treatment Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Varicella Zoster Infection Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Varicella Zoster Infection Treatment Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Varicella Zoster Infection Treatment Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Varicella Zoster Infection Treatment Drugs Sales Market Share by Country (2021-2032) Figure 41. China Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Varicella Zoster Infection Treatment Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Varicella Zoster Infection Treatment Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Varicella Zoster Infection Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Varicella Zoster Infection Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Varicella Zoster Infection Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Varicella Zoster Infection Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Varicella Zoster Infection Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Varicella Zoster Infection Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Varicella Zoster Infection Treatment Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Varicella Zoster Infection Treatment Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Acyclovir
  • Famciclovir
  • Valacyclovir
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Astrazeneca
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Roche
  • Merck
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Varicella Zoster Infection Treatment Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Varicella Zoster Infection Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Varicella Zoster Infection Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Varicella Zoster Infection Treatment Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Varicella Zoster Infection Treatment Drugs Market Dynamics
  1. 2.1 Varicella Zoster Infection Treatment Drugs Industry Trends
  2. 2.2 Varicella Zoster Infection Treatment Drugs Industry Drivers
  3. 2.3 Varicella Zoster Infection Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Varicella Zoster Infection Treatment Drugs Industry Restraints
3 Varicella Zoster Infection Treatment Drugs Market by Manufacturers
  1. 3.1 Global Varicella Zoster Infection Treatment Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Varicella Zoster Infection Treatment Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Varicella Zoster Infection Treatment Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Varicella Zoster Infection Treatment Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Varicella Zoster Infection Treatment Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Varicella Zoster Infection Treatment Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Varicella Zoster Infection Treatment Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Varicella Zoster Infection Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Varicella Zoster Infection Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Varicella Zoster Infection Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Varicella Zoster Infection Treatment Drugs Market by Type
  1. 4.1 Varicella Zoster Infection Treatment Drugs Type Introduction
  2. 4.1.1 Acyclovir
  3. 4.1.2 Famciclovir
  4. 4.1.3 Valacyclovir
  5. 4.1.4 Others
  6. 4.2 Global Varicella Zoster Infection Treatment Drugs Sales by Type
  7. 4.2.1 Global Varicella Zoster Infection Treatment Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Varicella Zoster Infection Treatment Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Varicella Zoster Infection Treatment Drugs Revenue by Type
  11. 4.3.1 Global Varicella Zoster Infection Treatment Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Varicella Zoster Infection Treatment Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Type (2021-2032)
5 Varicella Zoster Infection Treatment Drugs Market by Application
  1. 5.1 Varicella Zoster Infection Treatment Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Varicella Zoster Infection Treatment Drugs Sales by Application
  6. 5.2.1 Global Varicella Zoster Infection Treatment Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Varicella Zoster Infection Treatment Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Varicella Zoster Infection Treatment Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Varicella Zoster Infection Treatment Drugs Revenue by Application
  10. 5.3.1 Global Varicella Zoster Infection Treatment Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Varicella Zoster Infection Treatment Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Application (2021-2032)
6 Global Varicella Zoster Infection Treatment Drugs Sales by Region
  1. 6.1 Global Varicella Zoster Infection Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Varicella Zoster Infection Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Varicella Zoster Infection Treatment Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Varicella Zoster Infection Treatment Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Varicella Zoster Infection Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Varicella Zoster Infection Treatment Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Varicella Zoster Infection Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Varicella Zoster Infection Treatment Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Varicella Zoster Infection Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Varicella Zoster Infection Treatment Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Varicella Zoster Infection Treatment Drugs Revenue by Region
  1. 7.1 Global Varicella Zoster Infection Treatment Drugs Revenue by Region
  2. 7.1.1 Global Varicella Zoster Infection Treatment Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Varicella Zoster Infection Treatment Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Varicella Zoster Infection Treatment Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Varicella Zoster Infection Treatment Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Varicella Zoster Infection Treatment Drugs Revenue (2021-2032)
  8. 7.2.2 North America Varicella Zoster Infection Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Varicella Zoster Infection Treatment Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Varicella Zoster Infection Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Varicella Zoster Infection Treatment Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Varicella Zoster Infection Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Varicella Zoster Infection Treatment Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Astrazeneca
  2. 8.1.1 Astrazeneca Company Information
  3. 8.1.2 Astrazeneca Business Overview
  4. 8.1.3 Astrazeneca Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Astrazeneca Varicella Zoster Infection Treatment Drugs Product Portfolio
  6. 8.1.5 Astrazeneca Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Varicella Zoster Infection Treatment Drugs Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Varicella Zoster Infection Treatment Drugs Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Eli Lilly
  20. 8.4.1 Eli Lilly Company Information
  21. 8.4.2 Eli Lilly Business Overview
  22. 8.4.3 Eli Lilly Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly Varicella Zoster Infection Treatment Drugs Product Portfolio
  24. 8.4.5 Eli Lilly Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Varicella Zoster Infection Treatment Drugs Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Varicella Zoster Infection Treatment Drugs Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Novartis
  38. 8.7.1 Novartis Company Information
  39. 8.7.2 Novartis Business Overview
  40. 8.7.3 Novartis Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novartis Varicella Zoster Infection Treatment Drugs Product Portfolio
  42. 8.7.5 Novartis Recent Developments
  43. 8.8 Johnson & Johnson
  44. 8.8.1 Johnson & Johnson Company Information
  45. 8.8.2 Johnson & Johnson Business Overview
  46. 8.8.3 Johnson & Johnson Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Johnson & Johnson Varicella Zoster Infection Treatment Drugs Product Portfolio
  48. 8.8.5 Johnson & Johnson Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Varicella Zoster Infection Treatment Drugs Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
  55. 8.10 Abbott
  56. 8.10.1 Abbott Company Information
  57. 8.10.2 Abbott Business Overview
  58. 8.10.3 Abbott Varicella Zoster Infection Treatment Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Abbott Varicella Zoster Infection Treatment Drugs Product Portfolio
  60. 8.10.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Varicella Zoster Infection Treatment Drugs Value Chain Analysis
  2. 9.1.1 Varicella Zoster Infection Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Varicella Zoster Infection Treatment Drugs Production Mode & Process
  6. 9.2 Varicella Zoster Infection Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Varicella Zoster Infection Treatment Drugs Distributors
  9. 9.2.3 Varicella Zoster Infection Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst